ID   PP2AA_HUMAN             Reviewed;         309 AA.
AC   P67775; P05323; P13197;
DT   11-OCT-2004, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2004, sequence version 1.
DT   22-JUL-2015, entry version 121.
DE   RecName: Full=Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform;
DE            Short=PP2A-alpha;
DE            EC=3.1.3.16;
DE   AltName: Full=Replication protein C;
DE            Short=RP-C;
GN   Name=PPP2CA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=2849764; DOI=10.1093/nar/16.23.11365;
RA   Stone S.R., Mayer R., Wernet W., Maurer F., Hofsteenge J.,
RA   Hemmings B.A.;
RT   "The nucleotide sequence of the cDNA encoding the human lung protein
RT   phosphatase 2A alpha catalytic subunit.";
RL   Nucleic Acids Res. 16:11365-11365(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2837763; DOI=10.1073/pnas.85.12.4252;
RA   Arino J., Woon C.W., Brautigan D.L., Miller T.B. Jr., Johnson G.L.;
RT   "Human liver phosphatase 2A: cDNA and amino acid sequence of two
RT   catalytic subunit isotypes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:4252-4256(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1846293; DOI=10.1021/bi00215a014;
RA   Khew-Goodall Y., Mayer R.E., Maurer F., Stone S.R., Hemmings B.A.;
RT   "Structure and transcriptional regulation of protein phosphatase 2A
RT   catalytic subunit genes.";
RL   Biochemistry 30:89-97(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, Placenta, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   DEPHOSPHORYLATION OF SV40 LARGE-T ANTIGEN AND P53 PROTEIN.
RX   PubMed=1848668;
RA   Scheidtmann K.H., Mumby M.C., Rundell K., Walter G.;
RT   "Dephosphorylation of simian virus 40 large-T antigen and p53 protein
RT   by protein phosphatase 2A: inhibition by small-t antigen.";
RL   Mol. Cell. Biol. 11:1996-2003(1991).
RN   [6]
RP   METHYLATION AT LEU-309.
RX   PubMed=8206937;
RA   Favre B., Zolnierowicz S., Turowski P., Hemmings B.A.;
RT   "The catalytic subunit of protein phosphatase 2A is carboxyl-
RT   methylated in vivo.";
RL   J. Biol. Chem. 269:16311-16317(1994).
RN   [7]
RP   INTERACTION WITH IGBP1.
RX   PubMed=9647778; DOI=10.1006/bbrc.1998.8792;
RA   Chen J., Peterson R.T., Schreiber S.L.;
RT   "Alpha 4 associates with protein phosphatases 2A, 4, and 6.";
RL   Biochem. Biophys. Res. Commun. 247:827-832(1998).
RN   [8]
RP   MUTAGENESIS OF LEU-309.
RX   PubMed=10191253; DOI=10.1042/0264-6021:3390241;
RA   Bryant J.C., Westphal R.S., Wadzinski B.E.;
RT   "Methylated C-terminal leucine residue of PP2A catalytic subunit is
RT   important for binding of regulatory Balpha subunit.";
RL   Biochem. J. 339:241-246(1999).
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, AND ACTIVATION OF SV40 REPLICATION.
RX   PubMed=2555176;
RA   Virshup D.M., Kauffman M.G., Kelly T.J.;
RT   "Activation of SV40 DNA replication in vitro by cellular protein
RT   phosphatase 2A.";
RL   EMBO J. 8:3891-3898(1989).
RN   [10]
RP   INTERACTION WITH AXIN1, AND FUNCTION.
RX   PubMed=9920888; DOI=10.1074/jbc.274.6.3439;
RA   Hsu W., Zeng L., Costantini F.;
RT   "Identification of a domain of Axin that binds to the serine/threonine
RT   protein phosphatase 2A and a self-binding domain.";
RL   J. Biol. Chem. 274:3439-3445(1999).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH RAF1.
RX   PubMed=10801873; DOI=10.1074/jbc.M003259200;
RA   Abraham D., Podar K., Pacher M., Kubicek M., Welzel N., Hemmings B.A.,
RA   Dilworth S.M., Mischak H., Kolch W., Baccarini M.;
RT   "Raf-1-associated protein phosphatase 2A as a positive regulator of
RT   kinase activation.";
RL   J. Biol. Chem. 275:22300-22304(2000).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH SGOL1.
RX   PubMed=16580887; DOI=10.1016/j.devcel.2006.03.010;
RA   Tang Z., Shu H., Qi W., Mahmood N.A., Mumby M.C., Yu H.;
RT   "PP2A is required for centromeric localization of Sgo1 and proper
RT   chromosome segregation.";
RL   Dev. Cell 10:575-585(2006).
RN   [13]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH SGOL1.
RX   PubMed=16541025; DOI=10.1038/nature04663;
RA   Kitajima T.S., Sakuno T., Ishiguro K., Iemura S., Natsume T.,
RA   Kawashima S.A., Watanabe Y.;
RT   "Shugoshin collaborates with protein phosphatase 2A to protect
RT   cohesin.";
RL   Nature 441:46-52(2006).
RN   [14]
RP   INTERACTION WITH PIM3.
RX   PubMed=12473674; DOI=10.1074/jbc.M208246200;
RA   Losman J.A., Chen X.P., Vuong B.Q., Fay S., Rothman P.B.;
RT   "Protein phosphatase 2A regulates the stability of Pim protein
RT   kinases.";
RL   J. Biol. Chem. 278:4800-4805(2003).
RN   [15]
RP   INTERACTION WITH TP53.
RX   PubMed=17245430; DOI=10.1038/sj.emboj.7601519;
RA   Li H.H., Cai X., Shouse G.P., Piluso L.G., Liu X.;
RT   "A specific PP2A regulatory subunit, B56gamma, mediates DNA damage-
RT   induced dephosphorylation of p53 at Thr55.";
RL   EMBO J. 26:402-411(2007).
RN   [16]
RP   INTERACTION WITH SGOL2.
RX   PubMed=17485487; DOI=10.1083/jcb.200701122;
RA   Huang H., Feng J., Famulski J., Rattner J.B., Liu S.T., Kao G.D.,
RA   Muschel R., Chan G.K., Yen T.J.;
RT   "Tripin/hSgo2 recruits MCAK to the inner centromere to correct
RT   defective kinetochore attachments.";
RL   J. Cell Biol. 177:413-424(2007).
RN   [17]
RP   INTERACTION WITH IGBP1.
RX   PubMed=19818709; DOI=10.1016/j.molcel.2009.09.025;
RA   Kong M., Ditsworth D., Lindsten T., Thompson C.B.;
RT   "Alpha4 is an essential regulator of PP2A phosphatase activity.";
RL   Mol. Cell 36:51-60(2009).
RN   [18]
RP   INTERACTION WITH IGBP1.
RX   PubMed=20092282; DOI=10.1021/bi901837h;
RA   McConnell J.L., Watkins G.R., Soss S.E., Franz H.S., McCorvey L.R.,
RA   Spiller B.W., Chazin W.J., Wadzinski B.E.;
RT   "Alpha4 is a ubiquitin-binding protein that regulates protein
RT   serine/threonine phosphatase 2A ubiquitination.";
RL   Biochemistry 49:1713-1718(2010).
RN   [19]
RP   INTERACTION WITH GSK3B.
RX   PubMed=20080667; DOI=10.1073/pnas.0908133107;
RA   Xie D., Gore C., Liu J., Pong R.C., Mason R., Hao G., Long M.,
RA   Kabbani W., Yu L., Zhang H., Chen H., Sun X., Boothman D.A., Min W.,
RA   Hsieh J.T.;
RT   "Role of DAB2IP in modulating epithelial-to-mesenchymal transition and
RT   prostate cancer metastasis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2485-2490(2010).
RN   [20]
RP   ALTERNATIVE SPLICING (ISOFORM 2).
RX   PubMed=22167190; DOI=10.1074/jbc.M111.283341;
RA   Migueleti D.L., Smetana J.H., Nunes H.F., Kobarg J., Zanchin N.I.;
RT   "Identification and characterization of an alternatively spliced
RT   isoform of the human protein phosphatase 2Aalpha catalytic subunit.";
RL   J. Biol. Chem. 287:4853-4862(2012).
RN   [21]
RP   FUNCTION.
RX   PubMed=22613722; DOI=10.1074/jbc.M112.368613;
RA   Watkins G.R., Wang N., Mazalouskas M.D., Gomez R.J., Guthrie C.R.,
RA   Kraemer B.C., Schweiger S., Spiller B.W., Wadzinski B.E.;
RT   "Monoubiquitination promotes calpain cleavage of the protein
RT   phosphatase 2A (PP2A) regulatory subunit alpha4, altering PP2A
RT   stability and microtubule-associated protein phosphorylation.";
RL   J. Biol. Chem. 287:24207-24215(2012).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH MANGANESE IONS,
RP   AND COFACTOR.
RX   PubMed=17055435; DOI=10.1016/j.cell.2006.09.025;
RA   Xing Y., Xu Y., Chen Y., Jeffrey P.D., Chao Y., Lin Z., Li Z.,
RA   Strack S., Stock J.B., Shi Y.;
RT   "Structure of protein phosphatase 2A core enzyme bound to tumor-
RT   inducing toxins.";
RL   Cell 127:341-353(2006).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) IN COMPLEX WITH PPP2R1A AND
RP   PPME1.
RX   PubMed=18394995; DOI=10.1016/j.cell.2008.02.041;
RA   Xing Y., Li Z., Chen Y., Stock J.B., Jeffrey P.D., Shi Y.;
RT   "Structural mechanism of demethylation and inactivation of protein
RT   phosphatase 2A.";
RL   Cell 133:154-163(2008).
CC   -!- FUNCTION: PP2A is the major phosphatase for microtubule-associated
CC       proteins (MAPs). PP2A can modulate the activity of phosphorylase B
CC       kinase casein kinase 2, mitogen-stimulated S6 kinase, and MAP-2
CC       kinase. Cooperates with SGOL2 to protect centromeric cohesin from
CC       separase-mediated cleavage in oocytes specifically during meiosis
CC       I (By similarity). Can dephosphorylate SV40 large T antigen and
CC       p53/TP53. Activates RAF1 by dephosphorylating it at 'Ser-259'.
CC       {ECO:0000250, ECO:0000269|PubMed:10801873,
CC       ECO:0000269|PubMed:22613722, ECO:0000269|PubMed:9920888}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:17055435};
CC       Note=Binds 2 manganese ions per subunit.
CC       {ECO:0000269|PubMed:17055435};
CC   -!- SUBUNIT: PP2A consists of a common heterodimeric core enzyme,
CC       composed of PPP2CA a 36 kDa catalytic subunit (subunit C) and
CC       PPP2R1A a 65 kDa constant regulatory subunit (PR65 or subunit A),
CC       that associates with a variety of regulatory subunits. Proteins
CC       that associate with the core dimer include three families of
CC       regulatory subunits B (the R2/B/PR55/B55, R3/B''/PR72/PR130/PR59
CC       and R5/B'/B56 families), the 48 kDa variable regulatory subunit,
CC       viral proteins, and cell signaling molecules. Interacts with NXN;
CC       the interaction is direct (By similarity). Interacts with KCTD20
CC       (By similarity). Interacts with BTBD10 (By similarity). Interacts
CC       with TP53, SGOL1 and SGOL2. Interacts with AXIN1; the interaction
CC       dephosphorylates AXIN1. Interacts with PIM3; this interaction
CC       promotes dephosphorylation, ubiquitination and proteasomal
CC       degradation of PIM3. Interacts with RAF1. Interaction with IGBP1
CC       protects unassembled PPP2CA from degradative ubiquitination.
CC       Interacts with GSK3B (via C2 domain). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P63330, ECO:0000269|PubMed:10801873,
CC       ECO:0000269|PubMed:12473674, ECO:0000269|PubMed:16541025,
CC       ECO:0000269|PubMed:16580887, ECO:0000269|PubMed:17055435,
CC       ECO:0000269|PubMed:17245430, ECO:0000269|PubMed:17485487,
CC       ECO:0000269|PubMed:18394995, ECO:0000269|PubMed:19818709,
CC       ECO:0000269|PubMed:20080667, ECO:0000269|PubMed:20092282,
CC       ECO:0000269|PubMed:9647778, ECO:0000269|PubMed:9920888}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=5; IntAct=EBI-712311, EBI-296087;
CC       P39687:ANP32A; NbExp=2; IntAct=EBI-712311, EBI-359234;
CC       P03129:E7 (xeno); NbExp=3; IntAct=EBI-712311, EBI-866453;
CC       P04020:E7 (xeno); NbExp=2; IntAct=EBI-712311, EBI-7005254;
CC       P46695:IER3; NbExp=2; IntAct=EBI-712311, EBI-1748945;
CC       P78318:IGBP1; NbExp=10; IntAct=EBI-712311, EBI-1055954;
CC       Q61249:Igbp1 (xeno); NbExp=3; IntAct=EBI-712311, EBI-7002233;
CC       O14920:IKBKB; NbExp=3; IntAct=EBI-712311, EBI-81266;
CC       Q9Y6K9:IKBKG; NbExp=4; IntAct=EBI-712311, EBI-81279;
CC       Q969F8:KISS1R; NbExp=3; IntAct=EBI-712311, EBI-8481408;
CC       P97346:Nxn (xeno); NbExp=2; IntAct=EBI-712311, EBI-309684;
CC       P30153:PPP2R1A; NbExp=14; IntAct=EBI-712311, EBI-302388;
CC       P30154:PPP2R1B; NbExp=7; IntAct=EBI-712311, EBI-357094;
CC       Q9Y2T4:PPP2R2C; NbExp=3; IntAct=EBI-712311, EBI-1774058;
CC       Q15172:PPP2R5A; NbExp=3; IntAct=EBI-712311, EBI-641666;
CC       Q15173:PPP2R5B; NbExp=4; IntAct=EBI-712311, EBI-1369497;
CC       Q13362:PPP2R5C; NbExp=7; IntAct=EBI-712311, EBI-1266156;
CC       P28749:RBL1; NbExp=2; IntAct=EBI-712311, EBI-971402;
CC       Q08999:RBL2; NbExp=2; IntAct=EBI-712311, EBI-971439;
CC       Q04206:RELA; NbExp=6; IntAct=EBI-712311, EBI-73886;
CC       O43815:STRN; NbExp=3; IntAct=EBI-712311, EBI-1046642;
CC       O75663:TIPRL; NbExp=3; IntAct=EBI-712311, EBI-1054735;
CC       Q15645:TRIP13; NbExp=3; IntAct=EBI-712311, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16541025}.
CC       Nucleus {ECO:0000269|PubMed:16541025}. Chromosome, centromere
CC       {ECO:0000269|PubMed:16541025}. Cytoplasm, cytoskeleton, spindle
CC       pole {ECO:0000269|PubMed:16541025}. Note=In prometaphase cells,
CC       but not in anaphase cells, localizes at centromeres. During
CC       mitosis, also found at spindle poles. Centromeric localization
CC       requires the presence of SGOL2 (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PP2Acalpha1;
CC         IsoId=P67775-1; Sequence=Displayed;
CC       Name=2; Synonyms=PP2Acalpha2;
CC         IsoId=P67775-2; Sequence=VSP_044320;
CC         Note=Catalytically inactive, shows enhanced binding to IGBP1,
CC         and does not interact with the scaffolding subunit PPP2R1A.;
CC   -!- PTM: Reversibly methyl esterified on Leu-309 by leucine carboxyl
CC       methyltransferase 1 (LCMT1) and protein phosphatase methylesterase
CC       1 (PPME1). Carboxyl methylation influences the affinity of the
CC       catalytic subunit for the different regulatory subunits, thereby
CC       modulating the PP2A holoenzyme's substrate specificity, enzyme
CC       activity and cellular localization. {ECO:0000269|PubMed:8206937}.
CC   -!- PTM: Phosphorylation of either threonine (by autophosphorylation-
CC       activated protein kinase) or tyrosine results in inactivation of
CC       the phosphatase. Auto-dephosphorylation has been suggested as a
CC       mechanism for reactivation.
CC   -!- SIMILARITY: Belongs to the PPP phosphatase family. PP-1 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X12646; CAA31176.1; -; mRNA.
DR   EMBL; J03804; AAB38019.1; -; mRNA.
DR   EMBL; M60483; AAA36466.1; -; Genomic_DNA.
DR   EMBL; BC000400; AAH00400.1; -; mRNA.
DR   EMBL; BC002657; AAH02657.1; -; mRNA.
DR   EMBL; BC019275; AAH19275.1; -; mRNA.
DR   EMBL; BC031696; AAH31696.1; -; mRNA.
DR   CCDS; CCDS4173.1; -. [P67775-1]
DR   PIR; S01986; PAHU2A.
DR   RefSeq; NP_002706.1; NM_002715.2. [P67775-1]
DR   UniGene; Hs.105818; -.
DR   PDB; 2IAE; X-ray; 3.50 A; C/F=1-309.
DR   PDB; 2IE3; X-ray; 2.80 A; C=1-309.
DR   PDB; 2IE4; X-ray; 2.60 A; C=1-309.
DR   PDB; 2NPP; X-ray; 3.30 A; C/F=1-309.
DR   PDB; 2NYL; X-ray; 3.80 A; C/F=2-294.
DR   PDB; 2NYM; X-ray; 3.60 A; C/F=2-294.
DR   PDB; 3C5W; X-ray; 2.80 A; C=1-309.
DR   PDB; 3DW8; X-ray; 2.85 A; C/F=1-309.
DR   PDB; 3FGA; X-ray; 2.70 A; C=1-309.
DR   PDB; 3K7V; X-ray; 2.85 A; C=1-309.
DR   PDB; 3K7W; X-ray; 2.96 A; C=1-309.
DR   PDB; 3P71; X-ray; 2.70 A; C=1-309.
DR   PDB; 4I5L; X-ray; 2.43 A; C/F=1-309.
DR   PDB; 4I5N; X-ray; 2.80 A; C/F=1-309.
DR   PDB; 4IYP; X-ray; 2.80 A; C=6-153.
DR   PDB; 4LAC; X-ray; 2.82 A; C=1-309.
DR   PDBsum; 2IAE; -.
DR   PDBsum; 2IE3; -.
DR   PDBsum; 2IE4; -.
DR   PDBsum; 2NPP; -.
DR   PDBsum; 2NYL; -.
DR   PDBsum; 2NYM; -.
DR   PDBsum; 3C5W; -.
DR   PDBsum; 3DW8; -.
DR   PDBsum; 3FGA; -.
DR   PDBsum; 3K7V; -.
DR   PDBsum; 3K7W; -.
DR   PDBsum; 3P71; -.
DR   PDBsum; 4I5L; -.
DR   PDBsum; 4I5N; -.
DR   PDBsum; 4IYP; -.
DR   PDBsum; 4LAC; -.
DR   ProteinModelPortal; P67775; -.
DR   SMR; P67775; 2-296.
DR   BioGrid; 111507; 177.
DR   DIP; DIP-29395N; -.
DR   IntAct; P67775; 116.
DR   MINT; MINT-215645; -.
DR   STRING; 9606.ENSP00000418447; -.
DR   BindingDB; P67775; -.
DR   ChEMBL; CHEMBL4703; -.
DR   DrugBank; DB00163; Vitamin E.
DR   DEPOD; P67775; -.
DR   PhosphoSite; P67775; -.
DR   BioMuta; PPP2CA; -.
DR   DMDM; 54038809; -.
DR   MaxQB; P67775; -.
DR   PaxDb; P67775; -.
DR   PRIDE; P67775; -.
DR   DNASU; 5515; -.
DR   Ensembl; ENST00000481195; ENSP00000418447; ENSG00000113575.
DR   GeneID; 5515; -.
DR   KEGG; hsa:5515; -.
DR   UCSC; uc003kze.3; human. [P67775-1]
DR   CTD; 5515; -.
DR   GeneCards; GC05M133530; -.
DR   HGNC; HGNC:9299; PPP2CA.
DR   HPA; CAB003848; -.
DR   HPA; HPA043236; -.
DR   MIM; 176915; gene.
DR   neXtProt; NX_P67775; -.
DR   PharmGKB; PA33663; -.
DR   eggNOG; COG0639; -.
DR   GeneTree; ENSGT00550000074618; -.
DR   HOGENOM; HOG000172696; -.
DR   HOVERGEN; HBG000216; -.
DR   InParanoid; P67775; -.
DR   KO; K04382; -.
DR   OMA; KEVDQWI; -.
DR   OrthoDB; EOG74N5H2; -.
DR   PhylomeDB; P67775; -.
DR   TreeFam; TF105559; -.
DR   BioCyc; MetaCyc:HS03696-MONOMER; -.
DR   Reactome; REACT_11063; Degradation of beta-catenin by the destruction complex.
DR   Reactome; REACT_11065; Beta-catenin phosphorylation cascade.
DR   Reactome; REACT_111080; Spry regulation of FGF signaling.
DR   Reactome; REACT_12436; ERKs are inactivated.
DR   Reactome; REACT_12599; ERK/MAPK targets.
DR   Reactome; REACT_1383; Glycolysis.
DR   Reactome; REACT_150182; MASTL Facilitates Mitotic Progression.
DR   Reactome; REACT_150425; Resolution of Sister Chromatid Cohesion.
DR   Reactome; REACT_150471; Separation of Sister Chromatids.
DR   Reactome; REACT_1505; Integration of energy metabolism.
DR   Reactome; REACT_15334; DARPP-32 events.
DR   Reactome; REACT_160242; Initiation of Nuclear Envelope Reformation.
DR   Reactome; REACT_1857; Cyclin A/B1 associated events during G2/M transition.
DR   Reactome; REACT_19405; CTLA4 inhibitory signaling.
DR   Reactome; REACT_23879; Platelet sensitization by LDL.
DR   Reactome; REACT_263893; truncations of AMER1 destabilize the destruction complex.
DR   Reactome; REACT_263992; APC truncation mutants have impaired AXIN binding.
DR   Reactome; REACT_264030; AXIN missense mutants destabilize the destruction complex.
DR   Reactome; REACT_264034; disassembly of the destruction complex and recruitment of AXIN to the membrane.
DR   Reactome; REACT_264092; misspliced GSK3beta mutants stabilize beta-catenin.
DR   Reactome; REACT_264127; T41 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; REACT_264295; S45 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; REACT_264581; S33 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; REACT_264636; S37 mutants of beta-catenin aren't phosphorylated.
DR   Reactome; REACT_329; Inhibition of replication initiation of damaged DNA by RB1/E2F1.
DR   Reactome; REACT_355252; RHO GTPases Activate Formins.
DR   Reactome; REACT_682; Mitotic Prometaphase.
DR   Reactome; REACT_705; PP2A-mediated dephosphorylation of key metabolic factors.
DR   Reactome; REACT_75822; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   Reactome; REACT_821; Cyclin D associated events in G1.
DR   SignaLink; P67775; -.
DR   ChiTaRS; PPP2CA; human.
DR   EvolutionaryTrace; P67775; -.
DR   GeneWiki; PPP2CA; -.
DR   GenomeRNAi; 5515; -.
DR   NextBio; 21330; -.
DR   PRO; PR:P67775; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; P67775; -.
DR   CleanEx; HS_PPP2CA; -.
DR   ExpressionAtlas; P67775; baseline and differential.
DR   Genevisible; P67775; HS.
DR   GO; GO:0000775; C:chromosome, centromeric region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; NAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0000159; C:protein phosphatase type 2A complex; IDA:UniProtKB.
DR   GO; GO:0000922; C:spindle pole; IEA:UniProtKB-SubCell.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004721; F:phosphoprotein phosphatase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; TAS:UniProtKB.
DR   GO; GO:0006672; P:ceramide metabolic process; NAS:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0000188; P:inactivation of MAPK activity; NAS:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0000278; P:mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0007084; P:mitotic nuclear envelope reassembly; TAS:Reactome.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0010719; P:negative regulation of epithelial to mesenchymal transition; IMP:BHF-UCL.
DR   GO; GO:0042518; P:negative regulation of tyrosine phosphorylation of Stat3 protein; NAS:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:0071902; P:positive regulation of protein serine/threonine kinase activity; IMP:BHF-UCL.
DR   GO; GO:0006470; P:protein dephosphorylation; TAS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; NAS:UniProtKB.
DR   GO; GO:0045595; P:regulation of cell differentiation; NAS:UniProtKB.
DR   GO; GO:0006275; P:regulation of DNA replication; NAS:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; NAS:UniProtKB.
DR   GO; GO:0010033; P:response to organic substance; NAS:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; NAS:UniProtKB.
DR   GO; GO:0019932; P:second-messenger-mediated signaling; NAS:UniProtKB.
DR   Gene3D; 3.60.21.10; -; 1.
DR   InterPro; IPR004843; Calcineurin-like_PHP_apaH.
DR   InterPro; IPR029052; Metallo-depent_PP-like.
DR   InterPro; IPR006186; Ser/Thr-sp_prot-phosphatase.
DR   Pfam; PF00149; Metallophos; 1.
DR   PRINTS; PR00114; STPHPHTASE.
DR   SMART; SM00156; PP2Ac; 1.
DR   SUPFAM; SSF56300; SSF56300; 1.
DR   PROSITE; PS00125; SER_THR_PHOSPHATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Centromere; Chromosome;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Direct protein sequencing;
KW   Hydrolase; Manganese; Meiosis; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein phosphatase; Reference proteome.
FT   CHAIN         1    309       Serine/threonine-protein phosphatase 2A
FT                                catalytic subunit alpha isoform.
FT                                /FTId=PRO_0000058839.
FT   ACT_SITE    118    118       Proton donor. {ECO:0000250}.
FT   METAL        57     57       Manganese 1.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL        59     59       Manganese 1.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL        85     85       Manganese 1.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL        85     85       Manganese 2.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL       117    117       Manganese 2.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL       167    167       Manganese 2.
FT                                {ECO:0000269|PubMed:17055435}.
FT   METAL       241    241       Manganese 2.
FT                                {ECO:0000269|PubMed:17055435}.
FT   MOD_RES     307    307       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P63330}.
FT   MOD_RES     309    309       Leucine methyl ester.
FT                                {ECO:0000269|PubMed:8206937}.
FT   VAR_SEQ     193    246       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_044320.
FT   VARIANT      52     52       V -> A (in dbSNP:rs11552681).
FT                                /FTId=VAR_051735.
FT   MUTAGEN     309    309       L->A: Loss of binding to PP2A B-alpha
FT                                regulatory subunit.
FT                                {ECO:0000269|PubMed:10191253}.
FT   HELIX         3     18       {ECO:0000244|PDB:4I5L}.
FT   HELIX        25     39       {ECO:0000244|PDB:4I5L}.
FT   STRAND       44     48       {ECO:0000244|PDB:4I5L}.
FT   STRAND       50     55       {ECO:0000244|PDB:4I5L}.
FT   HELIX        62     72       {ECO:0000244|PDB:4I5L}.
FT   TURN         75     77       {ECO:0000244|PDB:4I5L}.
FT   STRAND       80     82       {ECO:0000244|PDB:4I5L}.
FT   STRAND       87     91       {ECO:0000244|PDB:4I5L}.
FT   HELIX        93    106       {ECO:0000244|PDB:4I5L}.
FT   TURN        108    110       {ECO:0000244|PDB:4I5L}.
FT   STRAND      111    113       {ECO:0000244|PDB:4I5L}.
FT   HELIX       121    127       {ECO:0000244|PDB:4I5L}.
FT   HELIX       129    137       {ECO:0000244|PDB:4I5L}.
FT   STRAND      138    140       {ECO:0000244|PDB:4I5L}.
FT   HELIX       141    150       {ECO:0000244|PDB:4I5L}.
FT   STRAND      155    159       {ECO:0000244|PDB:4I5L}.
FT   TURN        160    162       {ECO:0000244|PDB:4I5L}.
FT   STRAND      163    168       {ECO:0000244|PDB:4I5L}.
FT   HELIX       177    182       {ECO:0000244|PDB:4I5L}.
FT   STRAND      186    188       {ECO:0000244|PDB:3C5W}.
FT   STRAND      191    193       {ECO:0000244|PDB:4I5L}.
FT   HELIX       194    200       {ECO:0000244|PDB:4I5L}.
FT   STRAND      205    211       {ECO:0000244|PDB:4I5L}.
FT   STRAND      215    220       {ECO:0000244|PDB:4I5L}.
FT   HELIX       222    232       {ECO:0000244|PDB:4I5L}.
FT   STRAND      235    239       {ECO:0000244|PDB:4I5L}.
FT   STRAND      247    251       {ECO:0000244|PDB:4I5L}.
FT   TURN        252    255       {ECO:0000244|PDB:4I5L}.
FT   STRAND      256    259       {ECO:0000244|PDB:4I5L}.
FT   HELIX       265    267       {ECO:0000244|PDB:4I5L}.
FT   STRAND      273    278       {ECO:0000244|PDB:4I5L}.
FT   STRAND      284    289       {ECO:0000244|PDB:4I5L}.
SQ   SEQUENCE   309 AA;  35594 MW;  C602291F78F34555 CRC64;
     MDEKVFTKEL DQWIEQLNEC KQLSESQVKS LCEKAKEILT KESNVQEVRC PVTVCGDVHG
     QFHDLMELFR IGGKSPDTNY LFMGDYVDRG YYSVETVTLL VALKVRYRER ITILRGNHES
     RQITQVYGFY DECLRKYGNA NVWKYFTDLF DYLPLTALVD GQIFCLHGGL SPSIDTLDHI
     RALDRLQEVP HEGPMCDLLW SDPDDRGGWG ISPRGAGYTF GQDISETFNH ANGLTLVSRA
     HQLVMEGYNW CHDRNVVTIF SAPNYCYRCG NQAAIMELDD TLKYSFLQFD PAPRRGEPHV
     TRRTPDYFL
//
